GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
73.96
+3.07 (4.33%)
At close: Aug 19, 2026, 4:00 PM EDT
73.60
-0.36 (-0.49%)
After-hours: Aug 19, 2026, 7:52 PM EDT
GRAIL Revenue
GRAIL had revenue of $44.69M in the quarter ending June 30, 2026, with 25.72% growth. This brings the company's revenue in the last twelve months to $165.26M, up 23.07% year-over-year. In the year 2025, GRAIL had annual revenue of $147.17M with 17.18% growth.
Revenue (ttm)
$165.26M
Revenue Growth
+23.07%
P/S Ratio
19.99
Revenue / Employee
$181,608
Employees
910
Market Cap
3.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 147.17M | 21.58M | 17.18% |
| Dec 31, 2024 | 125.60M | 32.49M | 34.90% |
| Dec 31, 2023 | 93.11M | 37.56M | 67.61% |
| Jan 1, 2023 | 55.55M | 40.94M | 280.17% |
| Jan 2, 2022 | 14.61M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| RadNet | 2.27B |
| Sotera Health Company | 1.22B |
| NeoGenomics | 766.30M |
| Veracyte | 561.90M |
| CareDx | 458.09M |
| GeneDx Holdings | 454.43M |
| Twist Bioscience | 431.80M |
| BillionToOne | 397.41M |
GRAL News
- 8 days ago - GRAIL Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 12 days ago - US FDA to hold advisory meeting to review Grail's multi-cancer test - Reuters
- 12 days ago - Grail announces FDA advisory committee meeting to review Galleri test PMA - TheFly
- 12 days ago - GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PRNewsWire
- 14 days ago - GRAIL Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - GRAIL Earnings release: Q2 2026 - Filings
- 14 days ago - GRAIL Quarterly report: Q2 2026 - Filings
- 14 days ago - Grail reports Q2 EPS ($2.56), consensus ($2.43) - TheFly